Triggering Receptor Expressed on Myeloid Cells in Cutaneous Melanoma
Autor: | Victoria M. Lim, Devendra K. Agrawal, Austin Huy Nguyen, Ryan M. Trowbridge, Carleigh Koenck, William J. Hunter, Shannon K. Quirk, Mario V. Mitkov |
---|---|
Rok vydání: | 2015 |
Předmět: |
Tumor microenvironment
Innate immune system General Neuroscience Melanoma Inflammation General Medicine Biology medicine.disease General Biochemistry Genetics and Molecular Biology Proinflammatory cytokine Immune system Immunology Cutaneous melanoma medicine General Pharmacology Toxicology and Pharmaceutics medicine.symptom Receptor |
Zdroj: | Clinical and Translational Science. 8:441-444 |
ISSN: | 1752-8054 |
DOI: | 10.1111/cts.12308 |
Popis: | The tumor microenvironment plays an important role in the progression of melanoma, the prototypical immunologic cutaneous malignancy. The triggering receptor expressed on myeloid cells (TREM) family of innate immune receptors modulates inflammatory and innate immune signaling. It has been investigated in various neoplastic diseases, but not in melanoma. This study examines the expression of TREM-1 (a proinflammatory amplifier) and TREM-2 (an anti-inflammatory modulator and phagocytic promoter) in human cutaneous melanoma and surrounding tissue. Indirect immunofluorescence staining was performed on skin biopsies from 10 melanoma patients and staining intensity was semiquantitatively scored. Expression of TREM-1 and TREM-2 was higher in keratinocytes than melanoma tissue (TREM-1: p < 0.01; TREM-2: p < 0.01). Whereas TREM-2 was the dominant isoform expressed in normal keratinocytes, TREM-1 expression predominated in melanoma tissue (TREM-1 to TREM-2 ratio: keratinocytes = 0.78; melanoma = 2.08; p < 0.01). The increased TREM ratio in melanoma tissue could give rise to a proinflammatory and protumor state of the microenvironment. This evidence may be suggestive of a TREM-1/TREM-2 paradigm in which relative levels dictate inflammatory and immune states, rather than absolute expression of one or the other. Further investigation regarding this paradigm is warranted and could carry prognostic or therapeutic value in treatment for melanoma. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |